Invictus Joins Forces with
ABG, World-Leading
Branding Company, to Launch
Lifestyle-Inspired Cannabis Brands
Vancouver, BC
-- July 11, 2018 -- InvestorsHub NewsWire
-- INVICTUS MD STRATEGIES CORP.
("Invictus" or the
"Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1)
today
announced that it has entered into a licensing and
marketing services agreement with Authentic Brands Group
("ABG"),
a
global brand
owner and
marketing company, to develop a collection of
lifestyle-inspired cannabis brands that will launch
initially in
Canada and
rollout in key territories around the world.
Invictus will tap
into ABG's portfolio to
develop
all-new, lifestyle-inspired cannabis brands that feature
its
high-quality
products for patients and recreational adult users.
Products
will include
dried
flowers, oils and concentrates, and consumables that will be rolled out
through Invictus' wholly-owned and
fully-licensed producer,
Acreage
Pharms Ltd.
("Acreage Pharms").
"As
a first-mover in this new industry, we continue to build
a
foundation for
success by bringing together the world's leaders in business,
management,
finance, agriculture, and more," said
Dan Kriznic,
Chairman
and CEO
of Invictus.
"With
a portfolio of 30-plus iconic and
world-renowned brands that have significant
global
retail
presence, ABG is a leader in brand development
and our
partnership
with them
reinforces
our
long-term growth
plan."
Invictus will
explore key lifestyle brands from ABG's archival portfolio
that have positive
resonance, untapped potential, and naturally extend into cannabis
products,
such as Garden of Earthly Delights,
Zooey, and
Sinister. The company will also
tap
into ABG's brand
building expertise to potentially incubate an entirely new brand
for the space.
"We are constantly
looking for ways to innovate and activate some of the
more specialized intellectual
property within the
ABG portfolio, said Jamie Salter,
Founder,
Chairman, and CEO of ABG.
"We've
recognized that cannabis is a growing product category within
the health, wellness, and lifestyle
spaces and our partnership with Invictus
allows us to test
the waters in this important, emerging
market."
Headquartered in
New York City, ABG owns, manages, and builds the long-term value of
a global portfolio of Lifestyle,
Celebrity and Entertainment brands. ABG's brands have a retail
footprint that spans the luxury, specialty, department store,
mid-tier, and e-commerce channels and
4,381 branded freestanding stores and shop-in-shops
worldwide. For more information about ABG
and its brands, please visit abg-nyc.com.
About
Invictus
Invictus owns and
operates two cannabis production facilities, both with sales
licenses, under the ACMPR in Canada, with the vision of producing a
variety of high-quality and low-cost cannabis
products to the global market, as regulations permit. The Company's
wholly owned subsidiary, Acreage Pharms Ltd.
("Acreage Pharms"), is located in West-Central
Alberta. The Company's 50% owned AB Laboratories Inc.
("AB Labs"), is located in Hamilton,
Ontario. AB Ventures Inc. ("AB
Ventures")
owns 100 acres of land near Hamilton, Ontario, to be used for
future cannabis cultivation. Recently, the Company announced
that it has entered into a binding letter of intent for
an option to
acquire an applicant (the
"OptionCo") under the ACMPR.
Combined, assuming
exercise of the Option, the Company expects to have
approximately 262,000 and 846,000 square feet of cannabis
production capacity by the end of 2018 and 2019,
respectively.
Gene Simmons, music
legend and media mogul, conveys the vision of Invictus as the Chief
Evangelist Officer.
Finally, the
Company's 82.5% owned Future Harvest Development Ltd.
("Future Harvest") is a high-quality Fertilizer
and Nutrients manufacturer, based in Kelowna,
British Columbia. Future Harvest has been in operation for over 20
years under the brand Plant Life Products and Holland
Secret.
For more
information, please visit www.invictus-md.com.
On Behalf of the
Board,
Dan
Kriznic
Chairman and
CEO
About
Authentic Brands Group
Authentic Brands
Group (ABG) is a brand development, marketing, and entertainment
company, which owns a global portfolio of celebrity
and entertainment and lifestyle
brands. Headquartered in New York City, ABG manages, elevates, and
builds the long-term value of more than 33 consumer brands by
partnering with best-in-class manufacturers, wholesalers, and
retailers. Our brands have a global retail footprint in more than
50,000 points of sale across the luxury, specialty, department
store, mid-tier, mass, and e-commerce channels and more than 4,381
branded freestanding stores and shop-in-shops around the world. ABG
is committed to transforming brands by delivering compelling
product, content, business, and immersive brand experiences. We
create and activate original marketing strategies to drive the
success of our brands across all consumer touchpoints, platforms,
and emerging media. For more information,
please visit ABG-NYC.com.
Press
Contacts:
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
Invictus MD
Strategies Corp.
(604)
537-8676
Haley Steinberg
Director, Public
Relations
Authentic Brands
Group
(646) 612-7439
hsteinberg@abg-nyc.com
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing,
assumptions or expectations of future performance, including the
potential acquisition of OptionCo pursuant to the exercise of the
Option, and the potential production capacity of OptionCo, AB Labs,
AB Ventures and Acreage Pharms, are forward-looking statements and
contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events or results "may", "could", "should", "would" or
"occur". Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that the Company will be successful in exercising the
Option and obtaining TSX Venture Exchange approval of the
acquisition, that OptionCo, AB Labs, AB Ventures and Acreage Pharms
will be successful in reaching their potential production capacity,
OptionCo, AB Labs, AB Ventures and Acreage Pharms' production
facilities will be completed as anticipated, regulatory approval
will be granted as anticipated, OptionCo, AB Labs, AB Ventures and
Acreage Pharms will reach full production capacity on the timeline
anticipated by the Company, OptionCo will be granted its first and
second licenses, AB Labs will be granted its secondary license on
the terms and timeline anticipated by the Company, no unforeseen
construction delays will be experienced, and OptionCo will be
granted its sales license under the ACMPR on the terms and timeline
anticipated by the Company. These forward-looking statements are
subject to known and unknown risks, uncertainties and other factors
that may cause the actual results, level of activity, performance
or achievements of the Company to be materially different from
those expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, the Company
will not complete the acquisition of OptionCo, OptionCo, AB Labs,
AB Ventures and Acreage Pharms will not be successful in reaching
its potential production capacity, OptionCo, AB Labs, AB Ventures
and Acreage Pharms production facilities will not be completed as
anticipated, construction delays, regulatory approval will not be
granted as anticipated and therefore, the anticipated timing of
OptionCo, AB Labs, AB Ventures and Acreage Pharms reaching full
production capacity will be delayed, AB Labs will not be granted
their secondary license, OptionCo will not be granted its first and
second licenses and OptionCo will not be granted its sales license
under the ACMPR, and licenses or approvals being granted on terms
or timelines that are materially worse than expected by the
Company. Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
out-look that are incorporated by reference herein, except in
accordance with applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Jul 2023 to Jul 2024